Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Patent
1993-09-21
1997-01-14
Fleisher, Mindy
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
4242781, 514615, 514818, A61K 4505, A61K 4800, A61K 3100
Patent
active
055939724
ABSTRACT:
Methods of prophylactic and therapeutic immunization of an individual against pathogen infection, diseases associated with hyperproliferative cells and autoimmune diseases are disclosed. The methods comprise the steps of administering to cells of an individual, a nucleic acid molecule that comprises a nucleotide sequence that encodes a protein which comprises at least one epitope that is identical or substantially similar to an epitope of a pathogen antigen, a hyperproliferative cell associated protein or a protein associated with autoimmune disease respectively. In each case, nucleotide sequence is operably linked to regulatory sequences to enable expression in the cells. The nucleic acid molecule is free of viral particles and capable of being expressed in said cells. The cells may be contacted cells with a cell stimulating agent. Methods of prophylactically and therapeutically immunizing an individual against HIV are disclosed. Pharmaceutical compositions and kits for practicing methods of the present invention are disclosed.
REFERENCES:
patent: 4224404 (1980-09-01), Viza et al.
patent: 4394448 (1983-07-01), Szoka, Jr. et al.
patent: 4806463 (1989-02-01), Goodchild et al.
patent: 4945050 (1990-07-01), Sanford et al.
patent: 5017487 (1991-05-01), Stunnenberg et al.
patent: 5036006 (1991-07-01), Sanford et al.
patent: 5185254 (1993-02-01), Linnenbach
patent: 5466676 (1995-11-01), Booth et al.
F. D. Ledley (1991) Human Gene Therapy 2:77-83.
B. F. Haynes (1993) Science 260: 1279-1286.
A. Hoffenbach et al. (1989) The Journal of Immunology 142: 452-462.
D. Torpey et al. (1993) Clinical Immunology and Immunopathology 68(3): 263-272.
L. Butini et al. (1994) J. Cell. Biochem. Suppl. 18B: 147, Abstract J306.
A. Knuth et al (1991) Current Opinion in Immunology 3:659-664.
B. Wang et al (1993) Proc. Natl. Acad. Sci. USA 90:4156-4160.
D. J. Wells (1993) Febs Letters 332 (1,2):179-182.
R. F. Garry et al. (1990) Science 250: 1127-1129.
A. M. Schultz et al., AIDS 7(suppl. 1):S161-S170 (1993).
V. Glaser, Genetic Engineering News 16(1):6 (1996).
H. N. Eisen, "Introduction to Immune Responses," in Microbiology, Bernard D. Davis et al., eds. Hagerstown: Harper & Row, Publishers, 1980, p. 294.
Aldovini et al., "Mutations of RNA and Protein Sequences Involved in Human Immunodeficiency Virus Type 1 Packaging Result in Production of Noninfectious Virus," J. of Virology, 64: 1920-1926, 1990.
Benvenisty et al., "Direct introduction of genes into rats and expression of the genes," Proc. Natl. Acad. Sci. USA, 83:9551-9555, 1986.
Brandsma et al., "Use of a rapid, efficient inoculation method to induce papillomas by conttontail rabbit papillomavirus DNA shows that the E7 gene is required," Proc. Natl. Acad. Sci. USA, 88:4816-4820, 1991.
Desrosiers, "HIV with Multiple Gene Deletions as a Live Attenuated Vaccine for AIDS," AIDS Research and Human Retroviruses, 8:411-421, 1992.
Friedmann et al., "Progress Toward Human Gene Therapy," Science, 244:1275-1281, 1989.
Kaneda et al., "Increased Expression of DNA Cointroduced with Nuclear Protein in Adult Rat Liver," Science, 243:375-378, 1989.
Nicolau et al., "In vivo expression of rat insulin after intravenous administration of the liposome-entrapped gene for rat insulin I," Proc. Natl. Acad. Sci. USA, 80:1068-1072, 1983.
Ronen et al., "Expession of wild-type and mutant p53 proteins by recombinant vaccinia viruses," Nucleic Acids Research, 20:3435-3441, 1992.
Schauer et al., "The N-Terminal Region of HIV-1 Integrase is Required for Integration Activity, but not for DNA-Binding," Biochem. and Biophys. Res. Commun., 185:874-880, 1992.
Seeger et al., "The cloned genome of ground squirrel hepatitis virus is infectious in the animal," Proc. Natl. Acad. Sci. USA, 81:5849-5852, 1984.
Wu et al., "Receptor-mediated Gene Delivery and expression in Vivo," J. of Biological Chemistry, 263:14621-14624, 1988.
Yang et al., "In vivo and in vitro gene transfer to mammalian somatic cells by particle bombardment," Proc. Natl. Acad. Sci. USA, 87:9568-9572, 1990.
Zelenin et al., "High-velocity mechanical DNA transfer of the chloramphenicolacetyl transferase gene into rodent liver, kidney and mammary gland cells in organ explants and in vivo," FEBS Letts., 280:94-96, 1991.
Acsadi et al., "Human dystrophin expression in mdx mice after intramuscular injection of DNA constructs," Nature 352:815-818, 1991.
Anderson, W. French, "Prospects for Human Gene Therapy," Science 226:401-409, 1984.
Anilionis et al., "Structure of the glycoprotein gene in rabies virus," Nature 294:275278, 1981.
Benoit et al., "Destruction and regeneration of skeletal muscle after treatment with a local anaesthetic, bupivacaine (Marcaine.RTM.)," J. Anat. 107:547-556, 1970.
Berman et al., "Protection of chimpanzees from infection by HIV-1 after vaccination with recombinant glycoprotein gp120 but not gp160," Nature, 345:622-625, 1990.
Brigham et al., "Rapid Communication: In Vivo Transfection of Murine Lungs with a Functioning Prokaryotic Gene Using A Liposome Vehicle," American Journal of the Medical Sciences, 298:278-281, 1989.
Chaudhary et al., "A rapid method of cloning functional variable-region antibody genes in Escherichia coli as single-chain immunotoxins," Proc. Natl. Acad. Sci. USA, 87:1066-1070, 1990.
Chen et al., "HIV-1 gp41 contains two sites for interaction with several proteins on the helper T-lymphoid cell line, H9," AIDS, 6:533-539, 1992.
Cheng-Mayer et al., "Human Immunodeficiency virus can productively infect cultured human glial cells," Proc. Natl. Acad. Sci. USA, 84:3526-3530, 1987.
Crowe et al., "Improved cloning efficiency of polymerase chain reaction (PCR) products after proteinase K digestion", Nucleic Acids Research, 19:184, 1991.
Desquenne-Clark et al., "T-cell receptor peptide immunization leads to enhanced and chronic experimental allergic encephalomyelitis," Proc. Natl. Acad. Sci. USA, 88:7219-7223, 1991.
Di Fiore et al., "erbB-2 Is a Potent Oncogene When Overexpressed in NIH/3T3 Cells," Science, 237:178-182, 1987.
Dubensky et al., "Direct transfection of viral and plasmid DNA into the liver of spleen of mice," Proc. Natl. Acad. Sci. USA, 81:7529-7533, 1984.
Felgner et al., "Gene Therapeutics," Nature, 349:351-352, 1991.
Fisher et al., "A molecular clone of HTLV-III with biological activity," Nature, 316:262-265, 1985.
Fisher et al., "HIV infection is blocked in vitro by recombinant soluble CD4," Nature, 331:76-78, 1988.
Goudsmit et al., "Human antibody response to a strain-specific HIV-1 gp120 epitope associated with cell fusion inhibition," AIDS, 2:157-164, 1988.
Hahn et al., "Suppression of Murine Lupus Nephritis By Administration of an Anti-Idiotypic Antibody to Anti-DNA," J. of Immunology, 132:187-190, 1984.
Hall-Craggs, E. C. B., "Rapid Degeneration and Regeneration of a Whole Skeletal Muscle Following Treatment with Bupivacain (Marcain)," Experimental Neurology, 43:349-358, 1974.
Howley, Peter M., "Papillomavirinae and Their Replication," Virology, Chapter 58:1625-1650, 1990.
Howell et al., "Limited T-cell receptor Beta-chain heterogeneity among interleukin 2 receptor-positive synovial T cells suggests a role for superantigen in rheumatoid arthritis," Proc. Natl. Acad. Sci. USA, 88:10921-10925, 1991.
Israel et al., "Biological Activity of Polyoma Viral DNA in Mice and Hamsters," J. of Virology, 29:990-996, 1979.
Klein et al., "Transformation of Microbes, Plants and Animals by Particle Bombardment," Bio/Technology, 10:286-291, 1992.
Koenig et al., "Detection of AIDS Virus in Macrophages in Brian Tissue from AIDS Patients with Encephalopathy," Science, 233:1089-1093, 1986.
Kowalski et al., "Functional Regions of the Envelope Glycoprotein of Human Immunodeficiency Virus Type 1," Science, 237:1351-1355, 1987.
Langlois et al., "The Ability of Certain HIV Vaccines to Provoke Reactions Against Normal Cells," Science, 255:292-293, 1992.
Lasky et al., "Neutralization of the AIDS Retrovirus by Antibodies to a Recombinant Envelope Glycoprotein," Science, 233:209-212, 1986.
Lasky et al., "Delineation of a Region of the Human Immunodeficiency Virus Type 1 gp120 Glycoprotein Critical for Interact
Wang Bin
Weiner David B.
Williams William V.
Fleisher Mindy
Railey II Johnny F.
The Trustees of the University of Pennsylvania
The Wistar Institute
LandOfFree
Genetic immunization does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Genetic immunization, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Genetic immunization will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1388239